Why Is Silo Pharma (SILO) Stock Up 60% Today?

Naturally, the anticipation of a regulatory green light has contributed to the explosive sentiment in SILO stock. A few days ago, the underlying pharma made headlines when it announced a licensing deal for the development of SPC-14, a therapeutic for Alzheimer's. Regarding today's jump in SILO stock, the growing need for addressing PTSD has helped positively shift the underlying corporate narrative. Prior to the series of key developments, Silo suffered a significant drop in equity value in the past one-yea ...